UB Paderborn / Katalog / Suche / in CDI

1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents

JACC. Cardiovascular interventions, 2020-04, Vol.13 (7), p.820-830

2020

Volltextzugriff (PDF)

1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents

JACC. Cardiovascular interventions, 2020-04, Vol.13 (7), p.820

2020

Volltextzugriff (PDF)

123 Functional recovery after acute myocardial infarction: a comparison between angiography, electrocardiography and cardiovascular magnetic resonance measures of microvascular injury

Journal of cardiovascular magnetic resonance, 2008-10, Vol.10 (Suppl 1), p.A24-A24, Article A24

2008

Volltextzugriff (PDF)

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents

JACC. Cardiovascular interventions, 2018-03, Vol.11 (5), p.462-469

2018

Volltextzugriff (PDF)

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial

JACC. Cardiovascular interventions, 2018-03, Vol.11 (5), p.462-469

2018

Volltextzugriff (PDF)

Aspiration of embolized thrombus during primary percutaneous coronary intervention

Catheterization and cardiovascular interventions, 2009-05, Vol.73 (6), p.781-786

2009

Volltextzugriff (PDF)

Aspiration of embolized thrombus during primary percutaneous coronary intervention

Catheterization and Cardiovascular Interventions, 2009, Vol.73 (6), p.781-786

2009

Volltextzugriff (PDF)

Assessment of the relation between initial culprit vessel patency in acute ST-elevation myocardial infarction and endothelial function

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014-11, Vol.10 (7), p.784

2014

Volltextzugriff (PDF)

Athe remodeling index compared to actual vascular remodeling in atherosclerotic left main coronary arteries as assessed with long-term (≥12 months) serial intravascular ultrasound

Journal of the American College of Cardiology, 2006, Vol.47 (7), p.1363-1368

2006

Volltextzugriff (PDF)

Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia

The New England journal of medicine, 2012-07, Vol.367 (4), p.319-328

2012

Volltextzugriff (PDF)

Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute myocardial infarction: two-year clinical results of the COMFORTABLE AMI trial

Circulation. Cardiovascular interventions, 2014-06, Vol.7 (3), p.355-364

2014

Volltextzugriff (PDF)

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014-10, Vol.10 (6), p.664

2014

Volltextzugriff (PDF)

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents

Journal of the American College of Cardiology, 2013-06, Vol.61 (24), p.2406-2416

2013

Volltextzugriff (PDF)

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: 2-Year Follow-Up of the Randomized TWENTE Trial

Journal of the American College of Cardiology, 2013-06, Vol.61 (24), p.2406-2416

2013

Volltextzugriff (PDF)

Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: Insights from 2-year follow-up of the TWENTE trial

Catheterization and cardiovascular interventions, 2015-03, Vol.85 (4), p.524-531

2015

Volltextzugriff (PDF)

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012-10, Vol.8 (6), p.664

2012

Volltextzugriff (PDF)

Comparison of Frequency of Periprocedural Myocardial Infarction in Patients With and Without Diabetes Mellitus to Those With Previously Unknown but Elevated Glycated Hemoglobin Levels (from the TWENTE Trial)

The American journal of cardiology, 2012-12, Vol.110 (11), p.1561-1567

2012

Volltextzugriff (PDF)

A Completely Endovascular Solution for Transcatheter Aortic Valve Implantation Embolisation and Inversion into the Aortic Arch

EJVES vascular forum, 2021-01, Vol.52, p.13-16

2021

Volltextzugriff (PDF)

A Completely Endovascular Solution for Transcatheter Aortic Valve Implantation Embolisation and Inversion into the Aortic ArchWhat this paper adds

EJVES vascular forum, 2021-01, Vol.52, p.13-16

2021

Volltextzugriff (PDF)

Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting xience V stents in the randomized TWENTE trial: Comparison of 2-year clinical outcome

Catheterization and cardiovascular interventions, 2015-01, Vol.85 (1), p.74-81

2015

Volltextzugriff (PDF)

Coronary angiography after cardiac arrest: Rationale and design of the COACT Trial

The American heart journal, 2016-10, Vol.180, p.39-45

2016

Volltextzugriff (PDF)

Coronary Angiography after Cardiac Arrest without ST-Segment Elevation

The New England journal of medicine, 2019-04, Vol.380 (15), p.1397-1407

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents

1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents

123 Functional recovery after acute myocardial infarction: a comparison between angiography, electrocardiography and cardiovascular magnetic resonance measures of microvascular injury

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial

Aspiration of embolized thrombus during primary percutaneous coronary intervention

Aspiration of embolized thrombus during primary percutaneous coronary intervention

Assessment of the relation between initial culprit vessel patency in acute ST-elevation myocardial infarction and endothelial function

Athe remodeling index compared to actual vascular remodeling in atherosclerotic left main coronary arteries as assessed with long-term (≥12 months) serial intravascular ultrasound

Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia

Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute myocardial infarction: two-year clinical results of the COMFORTABLE AMI trial

Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents

Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II)

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: 2-Year Follow-Up of the Randomized TWENTE Trial

Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: Insights from 2-year follow-up of the TWENTE trial

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents

Comparison of Frequency of Periprocedural Myocardial Infarction in Patients With and Without Diabetes Mellitus to Those With Previously Unknown but Elevated Glycated Hemoglobin Levels (from the TWENTE Trial)

A Completely Endovascular Solution for Transcatheter Aortic Valve Implantation Embolisation and Inversion into the Aortic Arch

A Completely Endovascular Solution for Transcatheter Aortic Valve Implantation Embolisation and Inversion into the Aortic ArchWhat this paper adds

Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting xience V stents in the randomized TWENTE trial: Comparison of 2-year clinical outcome

Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry

Coronary angiography after cardiac arrest: Rationale and design of the COACT Trial

Coronary Angiography after Cardiac Arrest without ST-Segment Elevation

Aktive Filter

Suchergebnisse filtern